Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weifuchun plus proton pump inhibitor for gastric ulcer after ESD
ChiCTR2200059303Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Hangzhou Normal University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of weifuchun in gastric ulcer (3 arms), sponsored by Affiliated Hospital of Hangzhou Normal University. Primary endpoint: TCM Symptom Score. Started Jan 2022; status: recruiting.
02
Drugs
weifuchun
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on ChiCTR2200059303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059303.